It is widely recognised that putting the patient at the centre of a trial’s design can significantly improve the quality and accessibility of data collection. To do this, pharmaceutical companies need to first understand patients’ needs and expectations, as well as make sure that the trial participation fits into their daily lives. Keepinf the patients engaged in the study regimes allows for capturing their data more easily, which enables adapting the system responses in order to personalise content and provide target reports and summaries to all stakeholders in the clinical research. Tim Davis of Exco inTouch discusses why putting the patient at the centre of a trial’s design can significantly improve the quality and accessibility of data collection during clinical research.